MEDICINOVA INC Cash Flow Statement
MNOV|9 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 9 fiscal years. All figures from audited SEC 10-K filings.
MEDICINOVA INC used $10M in operating cash flow and negative free cash flow of $10M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$12.0M | -$8.6M | -$14.1M | -$14.1M | -$10.1M | -$9.2M | -$11.0M | -$25.7M | -$17.7M |
| Depreciation & Amortization | $20.1K | $20.3K | $17.7K | $17.7K | $26.1K | $40.2K | $69.5K | $41.9K | $41.9K |
| Operating Cash Flow | -$9.8M | -$7.4M | -$12.9M | -$12.9M | -$9.4M | $816.5K | -$11.9M | -$13.3M | -$13.3M |
| Capital Expenditures | $2.9K | $21.3K | $5.0K | $5.0K | $28.7K | $3.5K | $83.4K | $6.1K | $6.1K |
| Free Cash Flow | -$9.8M | -$7.5M | -$12.9M | -$12.9M | -$9.4M | $813.0K | -$11.9M | -$13.3M | -$13.3M |
| Share Buybacks | - | - | - | - | - | - | - | -$8.2K | -$8.2K |
| FCF Margin | -2395.4% | -745.2% | -1291.7% | - | -233.1% | - | -398260.5% | -6971.1% | -854.5% |